We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
NETGEAR
NTGR
$681M
| $731K | 0.01% |
28,931
+24,131
| +503% | +$703K |
|
1002
Zions Bancorporation
ZION
$10B
| $730K | 0.01% |
15,871
+7,330
| +86% | +$339K |
|
|
EGIO
1003
DELISTED
Edgio, Inc. Common Stock
EGIO
| $728K | 0.01% |
6,745
-21,054
| -76% | -$2.52M |
|
|
BNFT
1004
DELISTED
Benefitfocus, Inc.
BNFT
| $724K | 0.01% |
26,655
-206,538
| -89% | -$6.93M |
|
|
APU
1005
DELISTED
AmeriGas Partners, L.P.
APU
| $723K | 0.01% |
20,744
+18,792
| +963% | +$658K |
|
1006
Vanda Pharmaceuticals
VNDA
$314M
| $721K | 0.01% |
51,170
+51,156
| +365,400% | +$814K |
|
1007
PennyMac Financial
PFSI
$4.39B
| $719K | 0.01% |
32,422
-52,208
| -62% | -$1.16M |
|
1008
Cheesecake Factory
CAKE
$4.32B
| $716K | 0.01% |
16,379
-52,197
| -76% | -$2.44M |
|
1009
BioLife Solutions
BLFS
$1.46B
| $715K | 0.01% |
42,200
+11,922
| +39% | +$208K |
|
|
NEX
1010
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $710K | 0.01% |
+105,692
| New | +$988K |
|
1011
Brookfield Renewable
BEP
$9.74B
| $708K | 0.01% |
+38,389
| New | +$663K |
|
1012
PagSeguro Digital
PAGS
$2.62B
| $699K | 0.01% |
17,932
+15,924
| +793% | +$493K |
|
|
MRSN
1013
DELISTED
Mersana Therapeutics
MRSN
| $698K | 0.01% |
6,895
+5,825
| +544% | +$686K |
|
|
ONIT
1014
Onity Group
ONIT
$336M
| $686K | 0.01% |
22,090
-20,005
| -48% | -$534K |
|
|
TARO
1015
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $685K | 0.01% |
+8,014
| New | +$793K |
|
|
ARA
1016
DELISTED
American Renal Associates Holdings, Inc
ARA
| $684K | 0.01% |
92,039
+80,748
| +715% | +$533K |
|
|
BGFV
1017
DELISTED
Big 5 Sporting Goods
BGFV
| $683K | 0.01% |
350,280
+34,023
| +11% | +$83.2K |
|
1018
GATX Corp
GATX
$6.52B
| $677K | 0.01% |
+8,538
| New | +$649K |
|
|
TOWR
1019
DELISTED
Tower International, Inc.
TOWR
| $677K | 0.01% |
+34,715
| New | +$720K |
|
|
CHSP
1020
DELISTED
Chesapeake Lodging Trust
CHSP
| $673K | 0.01% |
23,684
-91,112
| -79% | -$2.65M |
|
1021
LPL Financial
LPLA
$26.5B
| $668K | 0.01% |
+8,194
| New | +$648K |
|
|
LLL
1022
DELISTED
L3 Technologies, Inc.
LLL
| $665K | 0.01% |
2,714
-9,413
| -78% | -$2.2M |
|
|
VRS
1023
DELISTED
Verso Corporation
VRS
| $661K | 0.01% |
34,709
+17,669
| +104% | +$357K |
|
1024
Apollo Global Management
APO
$71.6B
| $659K | 0.01% |
+19,230
| New | +$611K |
|
|
LSI
1025
DELISTED
Life Storage, Inc.
LSI
| $655K | 0.01% |
+10,334
| New | +$663K |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.